
young adults with predisposition. Ann Vasc Surg 2003;17:
270-6.
27. Rits Y, Oderich GS, Bower TC, Miller DV, Cooper L,
Ricotta JJ 2nd, et al. Interventions for mesenteric vasculitis.
J Vasc Surg 2010;51:392-400.e2.
28. Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA,
Panneton JM, et al. Takayasu’s arteritis: operative results
and inﬂuence of disease activity. J Vasc Surg 2006;43:64-71.
29. Min PK, Park S, Jung JH, Ko YG, Choi D, Jang Y, et al.
Endovascular therapy combined with immunosuppressive
treatment for occlusive arterial disease in patients with
Takayasu’s arteritis. J Endovasc Ther 2005;12:28-34.
30. Zettervall SL, Lo RC, Soden PA, Deery SE, Ultee KH, Pinto DS,
et al. Trends in treatment and mortality for mesenteric
ischemia in the United States from 2000 to 2012. Ann Vasc
Surg 2017;42:111-9.
31. Silva JA, White CJ, Collins TJ, Jenkins JS, Andry ME, Reilly JP,
et al. Endovascular therapy for chronic mesenteric
ischemia. J Am Coll Cardiol 2006;47:944-50.
32. Oderich GS, Erdoes LS, Lesar C, Mendes BC,
Gloviczki P, Cha S, et al. Comparison of covered stents
versus bare metal stents for treatment of chronic
atherosclerotic mesenteric arterial disease. J Vasc Surg
2013;58:1316-23.
33. Sarac TP, Altinel O, Kashyap V, Bena J, Lynden S,
Sruvastava S, et al. Endovascular treatment of